Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 686Squamous Cell Carcinoma of Head and Neck 203Thyroid Neoplasms 182Mouth Neoplasms 127Oropharyngeal Neoplasms 89Thyroid Nodule 88Breast Neoplasms 73Neoplasms 71Nasopharyngeal Carcinoma 69Laryngeal Neoplasms 65Lung Neoplasms 61Thyroid Cancer, Papillary 42Prostatic Neoplasms 41Carcinoma, Squamous Cell 40Nasopharyngeal Neoplasms 35Esophageal Neoplasms 35Deglutition Disorders 33Stomatitis 32Thyroid Diseases 31Colorectal Neoplasms 30Xerostomia 29Hypopharyngeal Neoplasms 29Uterine Cervical Neoplasms 28Melanoma 25Carcinoma, Non-Small-Cell Lung 24Motor Activity 23Tongue Neoplasms 22Sarcoma 22Pancreatic Neoplasms 22Colonic Neoplasms 22

Interventions

Thyrotropin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Recombinant Human Thyroid Stimulating Hormone × Head & Neck × Clear all
NCT06431620 2024-05-28

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Nanjing First Hospital, Nanjing Medical University

Phase NA Recruiting
15 enrolled
Head & Neck

Recombinant Human Thyroid Stimulating Hormone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡